Sri J.S.Deepak, IAS
Dept of Commerce
Ministry of Commerce and Industry
Govt. of India, New Delhi.
Sub:- DGFT public notification No. 59 dated 30.6.2011 – Clarifications – Requested.
Ref:- 1. Clarification Letter No. 15/71/2010 EP (Engg) dated 12.8.2011 of the Dept of Commerce.
2. Letter No.15/88/2011-EP (Engg) dated 4.10.2011 of the Dept of Commerce addressed
Pharmexcil is highly thankful for the timely clarifications on the subject notification to help the members to export the pharmaceutical consignment smoothly. We draw your kind attention on the above referred letters .
A. in the 1st cited reference, it is clarified that Bulk Drugs / Active Pharmaceutical Ingredients(APIs) are not required to have barcode on the labels . Formulations/Medicines with primary, secondary and tertiary packs are required to be labeled with barcode as per the notification. Many of the Pharmexcil members are informing the council that their consignments are stopped at DGFT offices for not labeling with barcode for the bulk drugs / APIs and officials are insisting for official clarification and clear guidelines from DGFT on this issue.
B. In the 2nd cited reference, it is clarified that the drugs/medicines manufactured on and after 1st oct 2011 are only required to have barcode for export purpose but some of the council members are informing the council that their drugs manufactured before 1st Oct 2011 are stopped at DGFT offices for lack of using barcode on their labels and directing the exporters to submit the clarification from DGFT.
In view of the above, we request you to help our members by advising DGFT to issue early clarifications on the above issues at the earliest
Copy submitted to Smt Mridul Jain, Director, Dept of Commerce for information.